Janus Kinase 2 (JAK2)

From Aaushi
Jump to navigation Jump to search

Function

Inhibition:

Structure

Compartment

Expression

expressed in blood, bone marrow & lymph node

Pathology

* frequency of V617F mutations

More general terms

Additional terms

References

  1. Ihle JN et al Signaling by the cytokine receptor superfamily: JAKs and STATs TIBS 19:222 1994 PMID: https://www.ncbi.nlm.nih.gov/pubmed/8048164
  2. Tefferi A, Gilliland DG. The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: status report & immediate implications for disease classification & diagnosis. Mayo Clin Proc. 2005 Jul;80(7):947-58. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16007902
  3. Atlas of Genetics & cytogenetics in oncology & Haematology http://atlasgeneticsoncology.org/Genes/JAK98.html
  4. UniProt http://www.uniprot.org/uniprot/O60674.html
  5. 5.0 5.1 Geriatric Review Syllabus, 7th edition Parada JT et al (eds) American Geriatrics Society, 2010

Database